OptiBiotix appoints director of business development

AIM-listed OptiBiotix Health has announced the appointment of Luis Gosalbez as director of business development with immediate effect.

The company, which develops compounds to tackle obesity, high cholesterol, diabetes and skin care, said Gosalbez brings a strong scientific background, an understanding of the microbiome and expertise in consumer healthcare, probiotics and the development of novel live biotherapeutic products.

Gosalbez has worked as a researcher, analyst and director of strategic projects exploring opportunities in consumer healthcare, the microbiome, and biotherapeutics.

OptiBiotix said his experience of the Asian market will help enhance the company’s understanding and capability to support wider internationalisation of products and create new joint development opportunities.

Chief executive officer Stephen O’Hara, said: "Luis's scientific and commercial experience in the microbiome space across food, biotech, and pharma provides additional breadth and capability to help capitalise on the growing number of microbiome opportunities.

“His multilingual skills and experience in working in overseas markets, particularly Asia, will help enhance our access to these markets and support commercialisation of our pipeline of opportunities.”

At 1350 BST, shares were up 1.3% to 77.47p.